Published in J Clin Pharmacol on September 01, 1990
The measurement structure of the Center for Epidemiologic Studies Depression Scale. J Pers Assess (1995) 2.39
Appraisals of control and predictability in adapting to a chronic disease. J Pers Soc Psychol (1987) 1.38
A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexes. Am J Cardiol (1984) 1.32
Predictors of work disability in rheumatoid arthritis patients. A five-year followup. Arthritis Rheum (1995) 1.23
Pharmacodynamics and side effects of flecainide acetate. Clin Pharmacol Ther (1986) 1.23
Work disability among women with rheumatoid arthritis. The relative importance of disease, social, work, and family factors. Arthritis Rheum (1989) 1.18
The biosynthesis of phospholipids and their precursors in rat liver involving de novo methylation, and base-exchange pathways, in vivo. Biochim Biophys Acta (1973) 1.16
Serum potassium, calcium and magnesium after resuscitation from ventricular fibrillation: a canine study. J Am Coll Cardiol (1987) 0.96
The Cardiac Arrhythmia Suppression Trial: first CAST ... then CAST-II. J Am Coll Cardiol (1992) 0.94
Factors associated with continued employment among patients with rheumatoid arthritis: a survival model. J Rheumatol (2001) 0.92
Effectiveness and costs of digoxin treatment for atrial fibrillation and flutter. Am J Cardiol (1993) 0.92
Frequency of hypokalemia after successfully resuscitated out-of-hospital cardiac arrest compared with that in transmural acute myocardial infarction. Am J Cardiol (1987) 0.91
Work disability among two cohorts of women with recent-onset rheumatoid arthritis: a survival analysis. Arthritis Rheum (2007) 0.89
Flecainide versus quinidine: results of a multicenter trial. Am J Cardiol (1984) 0.88
Effect of hypertonic sodium bicarbonate on encainide overdose. Am J Cardiol (1986) 0.84
Measuring disability: application of the Rasch model to activities of daily living (ADL/IADL). J Outcome Meas (2001) 0.84
Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias. J Am Coll Cardiol (1986) 0.83
Measuring disability: application of the Rasch model to activities of daily living (ADL/IADL). J Outcome Meas (2005) 0.82
Comparison of flecainide with quinidine for suppression of chronic stable ventricular ectopic depolarizations. A double-blind randomized study in ambulatory outpatients. Ann Intern Med (1983) 0.82
Attributional processes in rheumatoid arthritis patients. Arthritis Rheum (1987) 0.82
Antiarrhythmic drug therapy for suppression of ventricular arrhythmia: experience with 122 patients treated for two years. J Clin Pharmacol (1990) 0.79
Family work demands, employment demands and depressive symptoms in women with rheumatoid arthritis. Women Health (1995) 0.77
Employment patterns and their effect on health outcomes among women with rheumatoid arthritis followed for 7 years. J Rheumatol (1998) 0.77
Pirmenol: an antiarrhythmic drug with unique electrocardiographic features--a double-blind placebo-controlled comparison with quinidine. Clin Cardiol (1991) 0.77
Treating asthma by the guidelines: developing a medication management information system for use in primary care. Dis Manag (2004) 0.77
Characteristics of rheumatoid arthritis patients: who participates in long-term research and who drops out? Arthritis Care Res (2000) 0.76
Health insurance problems among insured rheumatoid arthritis patients. Arthritis Care Res (1995) 0.76
Characterizing the meaning of psychological distress in rheumatoid arthritis. Arthritis Care Res (1992) 0.75
Quinidine. Worse than adverse? Circulation (1991) 0.75
12-lead and continuous ECG recordings of subjects during inpatient administration of smoked cocaine. Drug Alcohol Depend (1994) 0.75
Correction and clarification on type of 24-hour electrocardiographic analyzers for ventricular arrhythmia described in a recent publication. Am J Cardiol (1988) 0.75
Variability of different methods for measurement of ECG intervals and ECG interval temporal variation. J Electrocardiol (1989) 0.75
Going beyond demographic characteristics in arthritis research: reflections on process in the experience of arthritis. Arthritis Care Res (1996) 0.75
Downward comparison and coping with serious medical problems. Am J Orthopsychiatry (1987) 0.75
Suppression of premature ventricular contractions: we can, but should we? Mayo Clin Proc (1986) 0.75
Cardiac drug toxicity: digitalis glycosides and calcium-channel and beta-blocking agents. Med J Aust (1990) 0.75
Atypical systolic clicks produced by prolapsing mitral valve masses. Am J Cardiol (1992) 0.75
Expanding the definition of disability: implications for planning, policy, and research. Milbank Q (1992) 0.75
Encainide-induced hyperglycemia. Am J Med (1988) 0.75
Pseudo AV block secondary to concealed premature His bundle depolarizations. Am Heart J (1991) 0.75
Reversal of desipramine toxicity in rats with polyclonal drug-specific antibody Fab fragments. J Lab Clin Med (1994) 0.75
The impact of selection bias on measurement of noninvasive test accuracy. Am J Cardiol (1993) 0.75
Efficacy, safety, hemodynamic effects, and pharmacokinetics of high-dose moricizine during short- and long-term therapy. Clin Pharmacol Ther (1987) 0.75
Rapid administration of high-dose human antibody Fab fragments to dogs: pharmacokinetics and toxicity. Fundam Appl Toxicol (1991) 0.75
The impact of Hurricane Hugo and the San Francisco earthquake on a sample of people with rheumatoid arthritis. Arthritis Care Res (1991) 0.75